Phase 3, Randomized, Placebo-Controlled Study of Stereotactic Body Radiotherapy (SBRT) with or Without Pembrolizumab in Patients with Inoperable Stage I/IIA NoneSmall-Cell Lung Cancer (NSCLC): KEYNOTE-867
62nd Annual Meeting of the American-Society-for-Radiation-Oncology (ASTRO), ELECTR NETWORK, 25 - 28 October 2020, vol.108, (Summary Text)
- Publication Type: Conference Paper / Summary Text
- Volume: 108
- Country: ELECTR NETWORK
- Hacettepe University Affiliated: Yes